These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1726673)

  • 21. The fluorometric microculture cytotoxicity assay.
    Lindhagen E; Nygren P; Larsson R
    Nat Protoc; 2008; 3(8):1364-9. PubMed ID: 18714304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
    Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
    Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.
    Bernhardt G; Reile H; Birnböck H; Spruss T; Schönenberger H
    J Cancer Res Clin Oncol; 1992; 118(1):35-43. PubMed ID: 1309532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
    Larsson R; Nygren P; Ekberg M; Slater L
    Leukemia; 1990 Aug; 4(8):567-71. PubMed ID: 2388483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
    Larsson R; Nygren P
    Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R; Kristensen J; Sandberg C; Nygren P
    Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the cytotoxic mechanisms mediated by the broad-spectrum antitumor alkaloid acronycine and selected semisynthetic derivatives.
    Shieh HL; Pezzuto JM; Cordell GA
    Chem Biol Interact; 1992 Jan; 81(1-2):35-55. PubMed ID: 1730147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide.
    Rünger TM; Emmert S; Schadendorf D; Diem C; Epe B; Hellfritsch D
    J Invest Dermatol; 2000 Jan; 114(1):34-9. PubMed ID: 10620112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basic study on the chemosensitivity test by miniaturized improved nucleic acid precursor incorporation assay (MINI assay)].
    Mogi M; Motohashi M; Hirota T; Ohshima K; Takahashi N; Kinoshita Y; Tanigawa M; Yoshinobu T; Koya Y; Masutani M
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):89-95. PubMed ID: 1688701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
    Hammouda MB; Riahi-Chebbi I; Souid S; Othman H; Aloui Z; Srairi-Abid N; Karoui H; Gasmi A; Magnenat EM; Wells TNC; Clemetson KJ; Rodríguez-López JN; Essafi-Benkhadir K
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):600-614. PubMed ID: 29196192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
    Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro.
    Licht T; Fiebig HH; Bross KJ; Herrmann F; Berger DP; Shoemaker R; Mertelsmann R
    Int J Cancer; 1991 Oct; 49(4):630-7. PubMed ID: 1917165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro chemosensitivity assay using a double-layer-agar system: human tumor cloning assay and thymidine incorporation assay].
    Tanigawa N; Shimomatsuya T; Fujii H; Yamakawa M; Muraoka R; Saitoh H
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):440-6. PubMed ID: 8452381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative effect of complexes of platinum (II) with plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
    Mikhaevich IS; Vlasenkova NK; Gerasimova GK
    Anticancer Drugs; 1992 Oct; 3(5):513-7. PubMed ID: 1450446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antitumor effect of Tiazofurin (TR) consists of anti-proliferative and anti-invasive elements.
    Tóvári J; Bocsi J; Ladányi A; Lapis K; Timár J
    Anticancer Res; 1996; 16(6A):3307-12. PubMed ID: 9042305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-proliferative activity and mechanism of action of titanocene dichloride.
    Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
    Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
    Wong SS; Sturm RA; Michel J; Zhang XM; Danoy PA; McGregor K; Jacobs JJ; Kaushal A; Dong Y; Dunn IS
    Biochem Pharmacol; 1994 Mar; 47(5):827-37. PubMed ID: 7510966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an enzyme assay for rapid assessment of Escherichia coli in seawaters.
    Caruso G; Crisafi E; Mancuso M
    J Appl Microbiol; 2002; 93(4):548-56. PubMed ID: 12234337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
    Tolis C; Photiou A; Camplejohn RS; Retsas S
    Anticancer Res; 1993; 13(1):161-6. PubMed ID: 8476208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.